CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), today announced plans to reorganize its business operations and pipeline priorities to support goals for long-term business ...
Ormat Technologies and Carbon Direct Capital co-lead Series B financing, which will support the development of Sage’s first next-generation geothermal power generation project Sage will deploy its ...
Strengthened financial position with expected annualized net savings of approximately $240 million anticipated to extend cash runway into 2026 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results